/

Sociétés

Qu

Non vérifié

Quiver Bioscience

Ce que nous écrivons

BiotechnologieIndustrieIndustrie pharmaceutiqueSantéScience

9 communiqués de presse

Voir tous les communiqués de presse

04/05/2026

Événements

Santé

Technique

Logiciels

Médecine - Divers

Industrie pharmaceutique

Biotechnologie

Quiver Bioscience Receives NIH HEAL Initiative Award to Advance Nav1.7 Antisense Therapy for Chronic Pain Through Early Clinical Trials

Source

Quiver Bioscience

Émetteur

1.00

0

13/04/2026

Industrie

Santé

Médecine - Divers

Science

Industrie pharmaceutique

Biotechnologie

Quiver Bioscience Receives Strategic Investment From the Porta Family to Advance UBE3A ASO Therapeutic Program for Dup15q Syndrome

Source

Quiver Bioscience

Émetteur

1.00

0

23/02/2026

Multimédia

Science

Technique

Associations/Professionnels

Biotechnologie

Industrie pharmaceutique

Santé

Technologies de l'Information

Marché du travail

Angelini Pharma and Quiver Bioscience Announce Strategic Research Collaboration and Licensing Agreement to Discover and Advance Novel Therapeutics for Genetic Epilepsies

Source

Quiver Bioscience

Émetteur

1.00

0

23/02/2026

Multimédia

Marché du travail

Science

Technique

Associations/Professionnels

Biotechnologie

Industrie pharmaceutique

Santé

Technologies de l'Information

Angelini Pharma e Quiver Bioscience annunciano la sigla di un accordo di collaborazione per la ricerca, lo sviluppo e la commercializzazione di nuove terapie per le epilessie genetiche

Source

Quiver Bioscience

Émetteur

1.00

0

01/07/2025

Science

Industrie pharmaceutique

Technique

Biotechnologie

Médecine - Divers

Santé

Quiver Bioscience Secures Non-Dilutive Funding to Enhance CNS Genetic Medicine Drug Discovery Platform Capabilities and Advance Powerful AI/ML-Based In Vitro / In Silico Predictor of CNS Drug Safety

Source

Quiver Bioscience

Émetteur

1.00

0

16/06/2025

Science

Technique

Technologies Diverses

Biotechnologie

Industrie pharmaceutique

Santé

Marché du travail

Industrie

Quiver Bioscience Appoints Graham Dempsey, PhD as Chief Executive Officer to Lead Scaling of AI-Driven CNS Platform and Advance Lead Program into the Clinic

Source

Quiver Bioscience

Émetteur

1.00

0

15/05/2025

Marché du travail

Industrie

Science

Biotechnologie

Industrie pharmaceutique

Santé

Quiver Bioscience and QurAlis Announce Research Collaboration to Advance Novel Therapeutic Approach for Fragile X Syndrome

Source

Quiver Bioscience

Émetteur

1.00

0

19/03/2025

Marché du travail

Industrie

Science

Biotechnologie

Santé Publique

Santé

Quiver Bioscience Announces Collaboration with the Dup15q Alliance to Advance Antisense Oligonucleotide Therapeutic Program

Source

Quiver Bioscience

Émetteur

1.00

0

21/11/2024

Santé

Biotechnologie

Science

Industrie pharmaceutique

Industrie

Quiver Bioscience Announces Publication in Nature Communications Biology Detailing Application of the Quiver Genomic Positioning System (Brain GPS) to Therapeutic Discovery in Fragile X Syndrome using Human Models and Machine Learning Analysis

Source

Quiver Bioscience

Émetteur

1.00

0

Followers

0

Compatibilité

0